Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice

Transgenic Research

Volumn 16, Issue 2, 2007, Pages 193-201

  Davie, Sarah A ^a   Maglione, Jeannie E ^a   Manner, Cathyryne K ^a   Young, Dmitri ^a   Cardiff, Robert D ^b   MacLeod, Carol L ^a   Ellies, Lesley G ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast; C57Bl 6J; Cancer; FVB NJ; iNOS; Mouse; Polyomavirus middle T antigen; Strain

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL; ARTICLE; C57BL MOUSE; COMPARATIVE STUDY; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; GENETICS; MOUSE; MOUSE MUTANT; PHENOTYPE;

ANIMALS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; PHENOTYPE;

MUS; MUS MUSCULUS; POLYOMAVIRUS;

EID: 33947321266     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-006-9056-9     Document Type: Article

References (34)

1. Boras-Granic K, Chang H, Grosschedl R, Hamel PA (2006) Lef1 is required for the transition of Wnt signaling from mesenchymal to epithelial cells in the mouse embryonic mammary gland. Dev Biol 295:219-231
2. Cardiff RD (2003) Mouse models of human breast cancer. Comp Med 53:250-253
3. Cardiff RD, Wellings SR (1999) The comparative pathology of human and mouse mammary glands. J Mammary Gland Biol Neoplasia 4:105-122
4. Eblaghie MC, Song SJ, Kim JY, Akita K, Tickle C, Jung HS (2004) Interactions between FGF and Wnt signals and Tbx3 gene expression in mammary gland initiation in mouse embryos. J Anat 205:1-13
5. Ellies LG, Fishman M, Hardison J, Kleeman J, Maglione J, Manner CK, Cardiff RD, MacLeod CL (2003) Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase. Int J Cancer 106:1-7
6. Fargiano AA, Desai KV, Green JE (2003) Interrogating mouse mammary cancer models: insights from gene expression profiling. J Mammary Gland Biol Neoplasia 8:321-334
7. Freund R, Dubensky T, Bronson R, Sotnikov A, Carroll J, Benjamin T (1992) Polyoma tumorigenesis in mice: evidence for dominant resistance and dominant susceptibility genes of the host. Virology 191:724-731
8. Gross LG (1983). Oncogenic Viruses, 3rd edn. Oxford, Pergamon Press
9. Guy C, Cardiff R, Muller W (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12:954-961
10. Guy C, Muthuswamy S, Cardiff R, Soriano P, Muller W (1994) Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev 8:23-32
11. Harris RE, Beebe-Donk J, Doss H, Burr Doss D (2005) Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade. Oncol Rep 13:559-583
12. Khuder SA, Mutgi AB (2001) Breast cancer and NSAID use: a meta-analysis. Br J Cancer 84:1188-1192
13. Kurachi H, Okamoto S, Oka T (1985) Evidence for the involvement of the submandibular gland epidermal growth factor in mouse mammary tumorigenesis. Proc Natl Acad Sci USA 82:5940-5943
14. Laubach V, Shesely E, Smithies O, Sherman P (1995) Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. PNAS, USA 92:10688-10692
15. Law LW, Ting RC, Leckband E (1967) Prevention of virus-induced neoplasms in mice through passive transfer of immunity by sensitized syngeneic lymphoid cells. Proc Natl Acad Sci USA 57:1068-1075
16. Le Voyer T, Lu Z, Babb J, Lifsted T, Williams M, Hunter K (2000) An epistatic interaction controls the latency of a transgene-induced mammary tumor. Mamm Genome 11:883-889
17. Lifsted T, Le Voyer T, Williams M, Muller W, Klein-Szanto A, Buetow KH, Hunter KW (1998) Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer 77:640-644
18. Lin EY, Nguyen AV, Russell RG, Pollard JW (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193:727-740
19. Lo HW, Hsu SC, Ali-Seyed M, Gunduz M, Xia W, Wei Y, Bartholomeusz G, Shih JY, Hung MC (2005) Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7:575-589
20. Loibl S, Buck A, Strank C, von Minckwitz G, Roller M, Sinn HP, Schini-Kerth V, Solbach C, Strebhardt K, Kaufmann M (2005) The role of early expression of inducible nitric oxide synthase in human breast cancer. Eur J Cancer 41:265-271
21. Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, Payette T, Pistone M, Stecker K, Zhang BM, et al. (2003) Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 100:5974-5979
22. Mailleux AA, Spencer-Dene B, Dillon C, Ndiaye D, Savona-Baron C, Itoh N, Kato S, Dickson C, Thiery JP, Bellusci S (2002) Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo. Development 129:53-60
23. Marti U, Burwen SJ, Wells A, Barker ME, Huling S, Feren AM, Jones AL (1991) Localization of epidermal growth factor receptor in hepatocyte nuclei. Hepatology 13:15-20
24. Molinolo A, Simian M, Vanzulli S, Pazos P, Lamb C, Montecchia F, Lanari C (1998). Involvement of EGF in medroxyprogesterone acetate (MPA)-induced mammary gland hyperplasia and its role in MPA-induced mammary tumors in BALB/c mice. Cancer Lett 126:49-57
25. Muller WJ, Neville MC (2001) Introduction: Signaling in mammary development and tumorigenesis. J Mammary Gland Biol Neoplasia 6:1-5
26. Qiu TH, Chandramouli GV, Hunter KW, Alkharouf NW, Green JE, Liu ET (2004) Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease. Cancer Res 64:5973-5981
27. Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49-54
28. Rosner A, Miyoshi K, Landesman-Bollag E, Xu X, Seldin DC, Moser AR, MacLeod CL, Shyamala G, Gillgrass AE, Cardiff RD (2002) Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am J Pathol 161:1087-1097
29. Ting RC, Law LW (1965) The role of thymus in transplantation resistance induced by polyoma virus. J Natl Cancer Inst 34:521-527
30. Veltmaat JM, Relaix F, Le LT, Kratochwil K, Sala FG, van Veelen W, Rice R, Spencer-Dene B, Mailleux AA, Rice DP, et al. (2006) Gli3-mediated somitic Fgf10 expression gradients are required for the induction and patterning of mammary epithelium along the embryonic axes. Development 133:2325-2335
31. Veltmaat JM, Van Veelen W, Thiery JP, Bellusci S (2004) Identification of the mammary line in mouse by Wnt10b expression. Dev Dyn 229:349-356
32. Webster MA, Hutchinson JN, Rauh MJ, Muthuswamy SK, Anton M, Tortorice CG, Cardiff RD, Graham FL, Hassell JA, Muller WJ (1998) Requirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol Cell Biol 18:2344-2359
33. Wells A, Marti U (2002) Signalling shortcuts: cell-surface receptors in the nucleus? Nat Rev Mol Cell Biol 3:697-702
34. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP (2004) Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 279:51630-51646